Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Chinese Network of Pediatric Antiretroviral Therapy (CN-PART)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by National Center for AIDS/STD Control and Prevention, China CDC
Sponsor:
Information provided by (Responsible Party):
National Center for AIDS/STD Control and Prevention, China CDC
ClinicalTrials.gov Identifier:
NCT01210924
First received: September 27, 2010
Last updated: November 20, 2013
Last verified: November 2013

September 27, 2010
November 20, 2013
April 2010
December 2015   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01210924 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Chinese Network of Pediatric Antiretroviral Therapy
Chinese Study of Pediatric Antiretroviral Therapy

This is an observational cohort in pediatric HIV patients in China. Children who receive antiretroviral drugs will be recruited in this study. The main objectives are as follows: 1. To establish simpler and smarter pediatric antiretroviral therapy in China including both first-line and second-line regimens. 2. To study the nature, characteristics and mechanisms of immunoreconstitution in HIV-infected children using the data and samples from the pediatric antiretroviral therapy cohort. 3. To establish a basic science and clinical research network based on the pediatric antiretroviral cohort.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

plamsa, PMBC, whole blood

Non-Probability Sample

Pediatric HIV-infected patients receiving triple antiretroviral drugs

Acquired Immunodeficiency Syndrome
Not Provided
Pediatric ART patients
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
400
December 2015
December 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • clinical diagnosis of HIV infection
  • receiving triple antiretroviral drugs

Exclusion Criteria:

  • clinical status not stable
Both
up to 15 Years
No
Contact: Fujie Zhang, MD +861063039086 treatment@chinaaids.cn
Contact: Yan Zhao, MD +861063039075 zhaoyanmgl@yahoo.com.cn
China
 
NCT01210924
Pediatric treatment 2010, 2008ZX10001-007
Yes
National Center for AIDS/STD Control and Prevention, China CDC
National Center for AIDS/STD Control and Prevention, China CDC
Not Provided
Principal Investigator: Fujie Zhang, MD National Center for AIDS/STD control and prevention
National Center for AIDS/STD Control and Prevention, China CDC
November 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP